lapaʻau ʻana i ka maʻi maʻi ʻaʻai kino metastatic

ʻO ka mālama ʻana i ka maʻi maʻi maʻi maʻi metastatic ke kālele nei i ka hoʻolōʻihi ʻana i ke ola a me ka hoʻomaikaʻi ʻana i ka maikaʻi o ke ola ke laha ʻia ka maʻi maʻi ma mua o nā māmā. ʻOkoʻa nā koho lapaʻau ma muli o ke ʻano maʻi maʻi, pae, mutations, a me ke olakino holoʻokoʻa. ʻO nā ala maʻamau e pili ana i ka chemotherapy, ka lāʻau i hoʻopaʻa ʻia, immunotherapy, radiation therapy, a me ke ʻoki. Nānā kēia alakaʻi i kēia mau koho me ka kikoʻī, e hāʻawi ana i nā ʻike i kā lākou mau hana, nā pōmaikaʻi, a me nā hopena ʻaoʻao.ʻO ka maʻi maʻi maʻi maʻi metastatic, i ʻike ʻia hoʻi ʻo ka maʻi maʻi maʻi maʻi maʻi maʻi IV, i ka wā e laha ai nā pūnaʻi maʻi ʻaʻai mai ka maʻi ʻaʻai mua i nā wahi mamao o ke kino. ʻO nā wahi maʻamau o ka metastasis ʻo ia ka lolo, iwi, ate, a me nā ʻeleʻele adrenal. ʻO nā ʻano o ka maʻi maʻi ʻāʻī ʻelua ʻelua mau ʻano nui o ka maʻi ʻaʻai māmā: ʻO ka maʻi maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi (NSCLC): ʻO ke ʻano maʻamau, ʻo ia hoʻi adenocarcinoma, squamous cell carcinoma, a me ka carcinoma cell nui. ʻO ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi (SCLC): ʻO kahi ʻano maʻi maʻi ʻāʻī e ulu wikiwiki aʻe e pili pū ana me ka puhi ʻana. ʻO ka diagnostic a me StagingDiagnosis ka mea maʻamau e pili ana i nā hoʻokolohua kiʻi (CT scans, PET scans, MRI), biopsies, a me ka hoʻāʻo molecular. Kōkua ke kau ʻana e hoʻoholo i ka nui o ka maʻi kanesa a alakaʻi i nā hoʻoholo lapaʻau. Nā Koho Lapaʻau no ka Metastatic Lung CancerKa pahuhopu lapaʻau ʻana i ka maʻi maʻi ʻaʻai kino metastatic ʻo ia ke kāohi i ka ulu ʻana o ke kanesa, mālama i nā hōʻailona, ​​a hoʻomaikaʻi i ka maikaʻi o ke ola. Hoʻopili pinepine ʻia nā hoʻolālā lapaʻau ma muli o ke kūlana kikoʻī o kēlā me kēia kanaka. Hoʻohana pinepine ʻia ma ke ʻano he lāʻau lapaʻau mua no ka maʻi maʻi ʻaʻai kino metastatic. ʻO nā lāʻau lapaʻau lapaʻau maʻamau ka: Platinum-based drugs (cisplatin, carboplatin) Taxanes (paclitaxel, docetaxel) Pemetrexed Gemcitabine Hiki ke loaʻa i nā hopena ʻaoʻao e like me ka nausea, luhi, lauoho lauoho, a me ka piʻi ʻana o ka maʻi. He mea nui ka hoʻāʻo ʻana i ka molekula e ʻike inā kūpono ka mea maʻi no ka lāʻau lapaʻau. ʻO kekahi mau pahuhopu maʻamau a me nā lāʻau lapaʻau e like me: EGFR (Epidermal Growth Factor Receptor): ʻO Gefitinib, erlotinib, afatinib, osimertinib. He mea maikaʻi loa kēia mau lāʻau lapaʻau i nā poʻe maʻi NSCLC me nā hoʻololi EGFR. ALK (Anaplastic Lymphoma Kinase): Crizotinib, alectinib, ceritinib, brigatinib, lorlatinib. Hoʻohana ʻia i nā maʻi maʻi NSCLC me nā hoʻonohonoho hou ʻana o ALK. BRAF: ʻO Dabrafenib, trametinib. Hoʻohana ʻia i nā mea maʻi NSCLC me nā hoʻololi BRAF V600E. ROS1: Crizotinib, entrectinib. Hoʻohana ʻia i nā maʻi maʻi NSCLC me nā fusions ROS1. NTRK: Larotrectinib, entrectinib. Hoʻohana ʻia i nā maʻi maʻi NSCLC me nā fusions NTRK. MET: Capmatinib, tepotinib. Hoʻohana ʻia i nā mea maʻi NSCLC me MET exon 14 skipping mutations. RET: Selpercatinib, pralsetinib. Hoʻohana ʻia i nā poʻe maʻi NSCLC me nā hui RET. ʻO nā lāʻau lapaʻau i manaʻo ʻia he liʻiliʻi nā hopena ʻaoʻao ma mua o ka chemotherapy, akā maikaʻi wale lākou inā loaʻa i ka maʻi kanesa ka pahuhopu kikoʻī. He ʻano maʻamau o ka immunotherapy i hoʻohana ʻia i loko o nā mea hoʻopaʻapaʻa hoʻopaʻa kino lapaʻau ʻana i ka maʻi maʻi ʻaʻai kino metastatic. Eia kekahi laʻana: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) Ipilimumab (Yervoy) ʻO kēia mau lāʻau lapaʻau e hoʻopaʻa i nā protein e pale ai i ka ʻōnaehana pale mai ka hoʻouka ʻana i nā cell cancer, e ʻae ana i ka ʻōnaehana pale e kau i kahi pane ikaika. Hiki i nā hopena ʻaoʻao ke komo i ka luhi, ka ʻūhū, ka maʻi maʻi, a me ka mumū o nā ʻano ʻano like ʻole. Hiki ke hoʻohana ʻia e hōʻemi i nā ʻōpū, hoʻomaha i ka ʻeha, a mālama paha i nā metastases ma nā wahi kikoʻī e like me ka lolo a me nā iwi. ʻO nā ʻano o ka lāʻau lapaʻau e like me: External beam radiation therapy. ka maʻi maʻi ʻaʻai kino metastatic, akā hiki ke noʻonoʻo ʻia i kekahi mau kūlana, e like me ka wehe ʻana i kahi metastasis kaʻawale a i ʻole e hoʻomaha i nā hōʻailona. No ka laʻana, ka Shandong Baofa Cancer Research Institute i kekahi manawa e hoʻohana i nā ʻenehana hōʻemi liʻiliʻi e hoʻoponopono i nā wahi metastatic kikoʻī. ʻO nā hoʻokolohua hoʻokolohua ʻo nā hoʻokolohua hoʻokolohua he noiʻi noiʻi e loiloi i nā lāʻau lapaʻau hou a i ʻole nā ​​hui pū ʻana o nā lāʻau lapaʻau. ʻO nā maʻi me ka maʻi maʻi ʻaʻai kino metastatic hiki ke noʻonoʻo e komo i nā hoʻokolohua lapaʻau no ke komo ʻana i nā lāʻau lapaʻau ʻokiʻoki. lapaʻau ʻana i ka maʻi maʻi ʻaʻai kino metastatic. Hiki i kēia ke komo: Hoʻoponopono ʻeha Kākoʻo meaʻai Ka hoʻoponopono ʻana i ka nausea a me ka luaʻi Kākoʻo hanu ʻo Prognosis and Survival RatesThe prognosis for ka maʻi maʻi ʻaʻai kino metastatic 'oko'a ma muli o kekahi mau kumu, e like me ke 'ano o ka ma'i ma'i 'a'ai, ka nui o ka laha, ke olakino holo'oko'a o ka mea ma'i, a me ka pane i ka lā'au lapa'au. ʻO nā holomua hou o ka lāʻau lapaʻau i hoʻopaʻa ʻia a me ka immunotherapy ua hoʻomaikaʻi i nā helu ola no kekahi mau maʻi. Wahi a ka American Cancer Society, he 7% ka nui o ke ola o 5 makahiki no ka ma'i kanesa ma'i ma'i ma'i (no ka hui 'ana o ka ma'i 'a'ai a pau, he 25%). [1] Hōʻike kēia i ke koʻikoʻi o ka noiʻi mau ʻana a me ka hoʻomohala ʻana i nā lāʻau lapaʻau hou. Eia ka hoʻohālikelike maʻalahi o nā koho lapaʻau, ko lākou kumu, a me nā hopena ʻaoʻao e hiki mai ana: Lapaʻau Manaʻo Hiki i nā hopena ʻaoʻao Chemotherapy Pepehi i nā maʻi kanesa ma loko o ke kino Nausea, luhi, lauoho lauoho, maʻi Targeted Therapy Block nā molekele kikoʻī e pili ana i ka ulu ʻana o ka maʻi maʻi. hiki ke komo i ka ʻili ʻili, ka maʻi ʻaʻai, nā pilikia o ka ate Immunotherapy Kōkua i ka ʻōnaehana pale e hoʻouka i nā pūnaewele maʻi maʻi ʻaʻai Ka luhi, ka ʻūlū, ka maʻi maʻi, ka mumū o nā kino Radiation Therapy E pepehi i nā maʻi maʻi maʻi ma kahi kikoʻī.ʻO ka mālama ʻana i ka maʻi maʻi maʻi maʻi metastatic he kahua paʻakikī a ulu. Ua hoʻomaikaʻi maikaʻi ka holomua ʻana o ka lāʻau lapaʻau a me ka immunotherapy i nā hopena no kekahi mau maʻi. He mea koʻikoʻi i nā poʻe maʻi ke hana pili me kā lākou hui mālama ola e hoʻomohala i kahi hoʻolālā lapaʻau pilikino e hoʻoponopono i kā lākou mau pono a me nā pahuhopu. E kūkākūkā mau me kekahi kauka lapaʻau kūpono no ka hōʻoia ʻana a me ka mālama ʻana i kekahi maʻi olakino.References[1] American Cancer Society. (n.d.). Ka helu o ke ola ma'i 'a'ai. Kiʻi ʻia mai https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html